Search

Your search keyword '"Kandolf-Sekulovic, Lidija"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Kandolf-Sekulovic, Lidija" Remove constraint Author: "Kandolf-Sekulovic, Lidija"
37 results on '"Kandolf-Sekulovic, Lidija"'

Search Results

1. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment–Update 2023

2. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention–Update 2023

4. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention

5. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment

6. Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC)

7. Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

9. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment–Update 2023

10. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention–Update 2023

13. Efficacy and safety of sequencing with vemurafenib (V) plus cobimetinib (C) followed by atezolizumab (Atezo) in patients (pts) with advanced BRAFV600-positive melanoma: Interim analysis of the ImmunoCobiVem study.

14. EMRseq : Registry-based outcome analysis on 1,000 patients with BRAF V600–mutated metastatic melanoma in Europe treated with either immune checkpoint or BRAF-/MEK inhibition

18. FC1-3: Does Phototherapy Induce Melanoma Simulators? Role of Confocal Microscopy in the Evaluation of Nevi Undergoing nbUVB Irradiation

19. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment

20. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment

21. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention

23. Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers

24. Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers

25. Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

26. Psoriasis is the independent factor for early atherosclerosis: A prospective study of cardiometabolic risk profile

28. A subpopulation that may correspond to granulocytic myeloid-derived suppressor cells reflects the clinical stage and progression of cutaneous melanoma

29. Clinicopathological characteristics, diagnosis and treatment of melanoma in Serbia: The Melanoma Focus Study

Catalog

Books, media, physical & digital resources